1. From the Department of Thrombosis and Hemostasis (P.H.R), Einthoven Laboratory for Experimental Vascular Medicine (P.H.R., H.H.V.), and Department of Clinical Oncology (H.H.V.), Leiden University Medical Center, Leiden, the Netherlands; Department of Vascular Medicine (S.M.), Academic Medical Center, Amsterdam, the Netherlands; and Rembrandt Institute of Cardiovascular Science (P.H.R., H.H.V., S.M.), Leiden University Medical Center and the Academic Medical Center, Leiden and Amsterdam, the...